Bart Frazzitta was told he had a 5% chance of surviving esophageal cancer. Twenty-five years later, he's still here and helping others.

Bart Frazzitta was told he had a 5% chance of surviving esophageal cancer. Twenty-five years later, he's still here and helping others.

The Penn physician-researcher has received more funding to advance his 'Trojan horse' for attacking gastroesophageal cancer.

Researchers evaluated demographic characteristics associated with survival trends in patients with squamous cell carcinoma of the upper esophagus.

Merck (MRK.N), opens new tab and Japan-based Eisai (4523.T), opens new tab said on Friday a combination of their therapies failed to extend the lives of patients with a type of esophageal cancer ...

For patients with resectable esophageal adenocarcinoma, perioperative chemotherapy with FLOT leads to improved survival compared with preoperative chemoradiotherapy.

TBC1D30 also has been shown to be highly methylated in colorectal cancer. NELL1 has been shown to be a diagnostic marker of both Barrett's esophagus and colorectal cancer, and hypermethylation of ...

Heartburn is the number one cancer warning sign for millions across the UK, according to experts. Statistics show Britain has the highest rates of throat or esophagus cancer in Europe and cases ...

A novel treatment approach combining neoadjuvant immunotherapy with chemoradiation showed promising results in patients with locally advanced esophageal ... of Sichuan Cancer Hospital, Chengdu ...

It was an abrupt turnaround. Six days earlier, Ms. Hudlow and her husband, who had late-stage esophageal cancer, had arrived on the tropical island full of hope that a novel blood-filtering ...

Feb. 18, 2025 — The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study ...